About the Company
We do not have any company description for ABVC BIOPHARMA, INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ABVC News
ABVC BioPharma Enters Licensing Agreement With OncoX For Commercialization Of BLEX 404
ABVC BioPharma, Inc. (ABVC) announced the company, together with its affiliate Rgene Corporation entered into a licensing agreement ...
Biopharma Layoffs Roundup
Novartis plans to cut as many as 680 jobs in development, Sanofi's pipeline reprioritization project will result in layoffs.
Theravance Biopharma (TBPH) Price Target Increased by 10.00% to 15.71
The average one-year price target for Theravance Biopharma (NasdaqGM:TBPH) has been revised to 15.71 / share. This is an ...
Why You Shouldn't Bet Against Vor Biopharma (VOR) Stock
One stock that might be an intriguing choice for investors right now is Vor Biopharma Inc. VOR. This is because this security ...
NeuBase Therapeutics, Inc.: NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
NeuBase Therapeutics, Inc. (Nasdaq: NBSE) ("NeuBase" or the "Company") today reported that it received a notice (the "Notice) on April 4, 2024 from the ...
Loading the latest forecasts...